STONEPINE CAPITAL MANAGEMENT, LLC UroGen Pharma Ltd. Transaction History

STONEPINE CAPITAL MANAGEMENT, LLC portfolio value:

$9.35M
portfolio value

STONEPINE CAPITAL MANAGEMENT, LLC quarter portfolio value change:

+1.59%
quarter

UroGen Pharma Ltd. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +1.19% 13.17K shares 255K $8.32 1.12M
Q2 2022 share Increase +313.29% 842.21K shares 6.75M $8.19 1.11M
Q1 2022 share Increase 0.00% 268.83K shares 2.34M $8.71 268.83K